Research and Development

Showing 15 posts of 9596 posts found.

FDA to study effects of medication during pregnancy

January 20, 2010 Research and Development, Sales and Marketing FDA, paediatric

A new US-based collaborative research programme to study the effects of medication on mothers and their babies has been launched. …

Dr Kai Lindevall re-appointed chief executive of Encorium

January 20, 2010 Research and Development Encorium, appointment, research and development

Dr Kai Lindevall has been re-appointed chief executive of contract research organisation (CRO) Encorium, having held the post in 2008 …

Dr Lloyd Payne joins Aquapharm Biodiscovery as research director

January 20, 2010 Research and Development Aquapharm Biodiscovery, appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Dr Lloyd Payne as its new research director. He joins Aquapharm from …

University of Cambridge joins Lilly’s open innovation group

January 20, 2010 Research and Development Cambridge University, OIDD, University of Cambridge, lilly

The University of Cambridge is to join Eli Lilly’s ‘Open Innovation Drug Discovery’ project. Lilly first launched its online portal …
Boehringer building at night

Boehringer targets ‘genome guardian’ protein for cancer collaboration

January 19, 2010 Research and Development Boehringer, Cancer, Priaxon, genome

Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …

Contract research news in brief

January 19, 2010 Research and Development Bioanalytical Systems, Charles River Laboratories, Invivodata, Quintiles, ReSearch Pharmaceutical, ReSearch Pharmaceutical Se Invivodata, Synomics Pharma

Our round-up of developments in the world of outsourced R&D includes job losses at Charles River, India’s SIRO Clinpharma buying …

Victoza pill trial begins

January 19, 2010 Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II

A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …
ICON Bruce Given

Bruce Given appointed chairman of ICON

January 18, 2010 Research and Development ICON, appointment, research and development

Irish contract research organisation ICON has appointed Bruce Given chairman.He succeeds out-going chairman John Climax who co-founded the company in 1990 …
Xceleron's Dr Graham Lappin

Talking R&D: Microdosing studies

January 18, 2010 Research and Development Microdosing, Talking R&D, Xceleron

A microdose study is performed at an early stage of development in order to obtain preliminary pharmacokinetic or distribution data …
Pfizer

Pfizer signs ‘personalised’ cancer collaboration

January 15, 2010 Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab

Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …

AstraZeneca taps Korean firm for antibiotics

January 15, 2010 Research and Development Asia, AstraZeneca, CrystalGenomics, Korea, anti-infectives

AstraZeneca has signed another licensing deal to bolster its anti-infectives business, this time signing a deal with Korean company CrystalGenomics …
SWest_2009

MDS promotes Steve West to chief executive

January 14, 2010 Research and Development appointment, mds, research and development

Canadian clinical research firm MDS has appointed Steve West chief executive. He was formerly president of MDS Nordion and chief …

FDA begins consumer transparency initiative

January 13, 2010 Research and Development, Sales and Marketing FDA, transparency

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …

Joseph Zakrzewski, executive chairman, Amarin

January 13, 2010 Research and Development Amarin, appointment, research and development

Dublin-headquartered biotech Amarin has appointed Joseph Zakrzewski executive chairman. He is currently the chief executive of Xcellerex, a Massachusetts-based biotechnology …

Sanofi Pasteur collaborates on novel biologics

January 12, 2010 Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
The Gateway to Local Adoption Series

Latest content